Viewing Study NCT04056468


Ignite Creation Date: 2025-12-24 @ 5:30 PM
Ignite Modification Date: 2026-01-06 @ 7:18 PM
Study NCT ID: NCT04056468
Status: COMPLETED
Last Update Posted: 2023-11-03
First Post: 2019-08-13
Is Gene Therapy: True
Has Adverse Events: True

Brief Title: A Study to Evaluate Pharmacokinetics (PK) and Safety of Oral Mobocertinib in Participants With Moderate or Severe Hepatic Impairment (HI) and Normal Hepatic Function
Sponsor: Millennium Pharmaceuticals, Inc.
Organization:

Key Dates - Follows AllAPIJSON File Order

Start Date: 2020-10-09
Start Date Type: ACTUAL
Primary Completion Date: 2022-02-05
Primary Completion Date Type: ACTUAL
Completion Date: 2022-02-26
Completion Date Type: ACTUAL
First Submit Date: 2019-08-13
First Submit QC Date: None
Study First Post Date: 2019-08-14
Study First Post Date Type: ACTUAL
Results First Submit Date: 2023-01-12
Results First Submit QC Date: None
Results First Post Date: 2023-11-03
Results First Post Date Type: ACTUAL
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2023-01-12
Last Update Post Date: 2023-11-03
Last Update Post Date Type: ACTUAL